Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mabxience Research S.l.

Clinical trials sponsored by Mabxience Research S.l., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New biosimilar aims to match leading melanoma treatment Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New biosimilar aims to match leading melanoma treatment

Disease control Recruiting now

This study tests whether MB11, a biosimilar (a nearly identical copy) of the cancer drug nivolumab (Opdivo), works as well as the original drug in people with advanced melanoma that cannot be removed by surgery or has spread. About 632 adults who have not yet been treated for the…

Phase 3 • Sponsor: mAbxience Research S.L. • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC